To gain more clinical insights of the effects of combined YAP and EGFR inhibition in lung cancer, we analyzed the effects of statin use in lung cancer patients with EGFR TKI prescription using Taiwan National Health Insurance Research Database. This evidence concerns the gene EGFR and lung cancer.